Skip to content

ARWR

Arrowhead Pharmaceuticals, Inc.

NASDAQ · USHealthcareBiotechnology
$71.65-3.57%

Price as of Jul 20, 2026

ARWR analysis

Arrowhead Pharmaceuticals, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for ARWR is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research